This study is in progress, not accepting new patients
A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy
Summary
- Eligibility
- for people ages 12 years and up (full criteria)
- Location
- at UC Davis UCSF
- Dates
- study startedcompletion around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Vertex Pharmaceuticals Incorporated
- ID
- NCT05444257
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- About 822 people participating
- Last Updated